Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Baseline Plasma NT-proBNP and Clinical...
Journal article

Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial

Abstract

BACKGROUND: N-terminal B type natriuretic peptide (NT-proBNP) is usually elevated in heart failure (HF) patients with reduced ejection fraction (EF). Less is known about NT-proBNP in HF with preserved EF (HF-PEF). We measured baseline NT-proBNP in 3562 HF-PEF enrolled patients in the Irbesartan in Heart Failure with Preserved Ejection Fraction trial. METHODS AND RESULTS: Patients with EF >or=45%, age >or=60 years, and either New York Heart …

Authors

Mckelvie RS; Komajda M; Mcmurray J; Zile M; Ptaszynska A; Donovan M; Carson P; Massie BM; Investigators I-P

Journal

Journal of Cardiac Failure, Vol. 16, No. 2, pp. 128–134

Publisher

Elsevier

Publication Date

2 2010

DOI

10.1016/j.cardfail.2009.09.007

ISSN

1071-9164